RE: Rize UCITS ICAV - Net Asset Value(s)23 Jul 2021 11:01
Rize UCITS ICAV is a Cannabis ETF fund.
It currently holds the below companies. I am guessing the mention in an RNS is suggestive that LIFE will be included/bought by the ETF?
Current ETF Holdings:
GROWGENERATION US39986L1098 18,35% USD
SCOTTS MIRACLE-GRO US8101861065 16,49% USD
AMYRIS US03236M2008 14,22% USD
ARENA PHARMS. US0400476075 9,12% USD
ZYNERBA PHARMS. US98986X1090 7,73% USD
CORBUS PHARMS. HOLDI US21833P1030 7,29% USD
INDIA GLOBALIZATION CAP. US45408X3089 5,40% USD
PERRIGO IE00BGH1M568 3,40% USD
ABBVIE US00287Y1091 3,35% USD
NOVARTIS US66987V1098 3,30% USD
TEVA PHARM. INDS. US8816242098 2,57% USD
CARA THERAPEUTICS US1407551092 1,61% USD
FSD PHARMA CA35954B2066 1,61% USD
NEWAGE US6501941032 1,60% USD
CBDMD US12482W1018 0,99% USD
GT BIOPHARMA US36254L2097 0,72% USD
CHARLOTTES WEB HLDGS. CA16106R1091 0,58% CAD
CANN GRP. AU000000CAN2 0,27% AUD
MGC PHARMS. AU000000MXC6 0,22% AUD
LITTLE GREEN PHARMA AU0000074924 0,15% AUD
TETRA BIO-PHARMA CA88166Y1007 0,11% CAD
BOTANIX PHARMS. AU000000BOT2 0,11% AUD
CARDIOL THERAPEUTICS CA14161Y2006 0,10% CAD
PHARMACIELO CA71716K1012 0,09% CAD
AUSCANN GRP. HLDGS. AU000000AC89 0,07% AUD
BOD AUS. AU000000BDA5 0,05% AUD
KHIRON LIFE SCIENCES CA49374L3065 0,05% CAD
ECOFIBRE AU0000040057 0,04% AUD
INMED PHARMS. CA4576375022 0,04% USD
EPSILON HLTHCR. AU0000137598 0,03% AUD
MEDLAB CLINICAL AU000000MDC8 0,03% AUD
Seems like a good place to be, any any big II buying is a +. I imagine they will be itching to buy, whether they can on AQUIS is another question.
Ballio